Efficacy and safety of vesatolimod in chronic hepatitis B: A systematic review and meta-analysis

Vesatolimod is a toll-like receptor (TLR) agonist that is thought to suppress chronic hepatitis B (HBV) infection. This systematic review aimed to assess the safety and efficacy of vesatolimod in treating chronic hepatitis B. METHODS: We included randomized clinical trials (RCTs) that assessed vesat...

Descripción completa

Detalles Bibliográficos
Autores principales: Omer, Ibrahim, Abuthiyab, Noorah, Al-Omari, Basil, Aletani, Tala, Betar, Manar, Alzaid, Nura, Hakami, Alqassem Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118312/
https://www.ncbi.nlm.nih.gov/pubmed/37083786
http://dx.doi.org/10.1097/MD.0000000000033609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118312/
https://www.ncbi.nlm.nih.gov/pubmed/37083786
http://dx.doi.org/10.1097/MD.0000000000033609

Ejemplares similares